HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 108 filers reported holding HERON THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,247 | -10.8% | 11,833 | 0.0% | 0.00% | – |
| Q2 2023 | $13,727 | -55.1% | 11,833 | -41.5% | 0.00% | – |
| Q1 2023 | $30,557 | -72.4% | 20,237 | -54.4% | 0.00% | – |
| Q4 2022 | $110,863 | -42.3% | 44,345 | -2.6% | 0.00% | – |
| Q3 2022 | $192,000 | -7.7% | 45,538 | -38.7% | 0.00% | – |
| Q2 2022 | $208,000 | -50.2% | 74,347 | +1.5% | 0.00% | – |
| Q1 2022 | $418,000 | -36.5% | 73,233 | +1.6% | 0.00% | – |
| Q4 2021 | $658,000 | -14.3% | 72,046 | +0.3% | 0.00% | – |
| Q3 2021 | $768,000 | -7.1% | 71,825 | +34.8% | 0.00% | – |
| Q2 2021 | $827,000 | -4.3% | 53,298 | 0.0% | 0.00% | – |
| Q1 2021 | $864,000 | -22.6% | 53,298 | +1.0% | 0.00% | – |
| Q4 2020 | $1,116,000 | +42.5% | 52,766 | -0.2% | 0.00% | – |
| Q3 2020 | $783,000 | -6.2% | 52,882 | -6.8% | 0.00% | – |
| Q2 2020 | $835,000 | +65.3% | 56,710 | +31.6% | 0.00% | – |
| Q1 2020 | $505,000 | -54.0% | 43,083 | -7.9% | 0.00% | -100.0% |
| Q4 2019 | $1,099,000 | +45.8% | 46,785 | +14.8% | 0.00% | – |
| Q3 2019 | $754,000 | +38.9% | 40,740 | +39.6% | 0.00% | – |
| Q2 2019 | $543,000 | -20.1% | 29,184 | +4.8% | 0.00% | – |
| Q1 2019 | $680,000 | -5.0% | 27,852 | +1.0% | 0.00% | -100.0% |
| Q4 2018 | $716,000 | -12.6% | 27,564 | +6.5% | 0.00% | 0.0% |
| Q3 2018 | $819,000 | +104.8% | 25,885 | +151.7% | 0.00% | – |
| Q2 2018 | $400,000 | +44.4% | 10,286 | +2.3% | 0.00% | – |
| Q1 2018 | $277,000 | +33.2% | 10,057 | -11.6% | 0.00% | – |
| Q4 2017 | $208,000 | +11.8% | 11,372 | -1.9% | 0.00% | – |
| Q3 2017 | $186,000 | +18.5% | 11,590 | +2.1% | 0.00% | – |
| Q2 2017 | $157,000 | +15.4% | 11,354 | +26.6% | 0.00% | – |
| Q1 2017 | $136,000 | +33.3% | 8,971 | +13.9% | 0.00% | – |
| Q4 2016 | $102,000 | +54.5% | 7,873 | +103.3% | 0.00% | – |
| Q3 2016 | $66,000 | -12.0% | 3,873 | -8.0% | 0.00% | – |
| Q2 2016 | $75,000 | -9.6% | 4,211 | 0.0% | 0.00% | – |
| Q1 2016 | $83,000 | -29.7% | 4,211 | -1.8% | 0.00% | – |
| Q4 2015 | $118,000 | +24.2% | 4,290 | 0.0% | 0.00% | – |
| Q3 2015 | $95,000 | -26.9% | 4,290 | 0.0% | 0.00% | – |
| Q2 2015 | $130,000 | – | 4,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |